IRIDEX stockholders approve doubling authorized shares to 63.5M and 1M share increase in equity plan

IRIDEX CORP

Authorized common stock increased from 30M to 63.5M shares; Restated Charter effective June 11, 2025.
2008 Equity Incentive Plan amended: reserve increased by 1M shares (total 6.85M), term extended to June 11, 2035.
Stockholders approved removal of 19.99% issuance limit for conversion of Series B Preferred and $4M note held by Novel.
All director nominees elected; BPM LLP ratified as auditor for FY2026; say-on-pay approved with one-year frequency.
Series B Preferred (600k shares) voted in favor of all proposals; common vote percentages ranged 80-92% for director elections.

item 5.02item 5.03item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.